Moleculin Biotech Statistics
Total Valuation
MBRX has a market cap or net worth of $4.41 million. The enterprise value is -$2.86 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, before market open.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MBRX has 14.13 million shares outstanding. The number of shares has increased by 144.32% in one year.
Current Share Class | 14.13M |
Shares Outstanding | 14.13M |
Shares Change (YoY) | +144.32% |
Shares Change (QoQ) | +85.41% |
Owned by Insiders (%) | 0.66% |
Owned by Institutions (%) | 1.62% |
Float | 11.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 196.16 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 10.71.
Current Ratio | 1.35 |
Quick Ratio | 1.12 |
Debt / Equity | 10.71 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -214.79% and return on invested capital (ROIC) is -143.05%.
Return on Equity (ROE) | -214.79% |
Return on Assets (ROA) | -62.45% |
Return on Invested Capital (ROIC) | -143.05% |
Return on Capital Employed (ROCE) | -183.52% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.37M |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.95% in the last 52 weeks. The beta is 1.56, so MBRX's price volatility has been higher than the market average.
Beta (5Y) | 1.56 |
52-Week Price Change | -90.95% |
50-Day Moving Average | 0.83 |
200-Day Moving Average | 1.62 |
Relative Strength Index (RSI) | 24.39 |
Average Volume (20 Days) | 5,255,422 |
Short Selling Information
The latest short interest is 1.93 million, so 13.69% of the outstanding shares have been sold short.
Short Interest | 1.93M |
Short Previous Month | 602,992 |
Short % of Shares Out | 13.69% |
Short % of Float | 16.35% |
Short Ratio (days to cover) | 2.21 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -25.91M |
Pretax Income | -26.82M |
Net Income | -23.23M |
EBITDA | -25.78M |
EBIT | -25.91M |
Earnings Per Share (EPS) | -$4.50 |
Full Income Statement Balance Sheet
The company has $7.72 million in cash and $450,000 in debt, giving a net cash position of $7.27 million or $0.51 per share.
Cash & Cash Equivalents | 7.72M |
Total Debt | 450,000 |
Net Cash | 7.27M |
Net Cash Per Share | $0.51 |
Equity (Book Value) | 42,000 |
Book Value Per Share | 0.00 |
Working Capital | 2.44M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$21.71 million and capital expenditures -$13,000, giving a free cash flow of -$21.72 million.
Operating Cash Flow | -21.71M |
Capital Expenditures | -13,000 |
Free Cash Flow | -21.72M |
FCF Per Share | -$1.54 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MBRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -144.32% |
Shareholder Yield | -144.32% |
Earnings Yield | -526.66% |
FCF Yield | -492.49% |
Analyst Forecast
The average price target for MBRX is $5.33, which is 1,607.24% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.33 |
Price Target Difference | 1,607.24% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | Mar 22, 2024 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |